Cutler Group LP Karyopharm Therapeutics Inc. Call Options Transaction History

Cutler Group LP

7 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q3 2022 Oct 25, 2022	SELL	$4.08 - $5.82 $35,904 - $51,216	-8,800 Reduced 46.32%	10,200 $2,000
Q2 2022 Aug 04, 2022	SELL	$4.15 - $8.37 $196,710 - $396,737	-47,400 Reduced 71.39%	19,000 $3,000
Q1 2022 Apr 14, 2022	BUY	$5.91 - $14.38 $392,424 - $954,832	66,400 New	66,400 $44,000
Q2 2020 Jul 22, 2020	SELL	$16.6 - $25.25 $11,620 - $17,675	-700 Closed	0 $0
Q1 2020 May 07, 2020	BUY	$14.38 - $27.72 $10,066 - $19,404	700 New	700 $0
Q4 2017 Jan 17, 2018	SELL	$9.15 - $11.99 $96,075 - $125,895	-10,500 Closed	0 $0
Q3 2017 Oct 17, 2017	BUY	$8.15 - $11.16 $85,575 - $117,180	10,500	10,500 $19,000

56.5M

258K

81.2K

Ticker KPTI
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 79,806,600
Market Cap $49.5M
Description
Karyopharm Therapeutics Inc., a commercial-stage pharmaceutical company, discovers, develops, and commercializes drugs directed against nuclear export for the treatment of cancer and other diseases. The company discovers, develops, and commercializes novel and Selective Inhibitor of Nuclear Export (SINE) compounds function by binding with and in...

Get notified when there are updates to the investment portfolio of Cutler Group LP, based on Form 13F filings with the SEC.

Stay updated on Cutler Group LP with notifications on news.